[PubMed] [Google Scholar] 13. flavivirus. This was confirmed when the agent was cloned by Houghton and colleagues at the Chiron Corporation in 1987 and renamed the hepatitis C computer virus (HCV). In 1990 a donor screening assay for HCV was launched nationwide and by 1997 PTH experienced virtually disappeared with rates now mathematically estimated to be one case per 2 million transfusions, compared to a 30% incidence before 1970. Clinical and molecular studies of HCV have shown that it results in persistent contamination in 75% to 85% of cases due to its high replication rate, its existence as a quasispecies with a high mutation rate and the ability of HCV proteins to blunt and ultimately exhaust the HCV immune response. Although HCV contamination is usually clinically and histologically moderate in most patients, it can lead to progressive fibrosis over the CYN-154806 course of decades in 30% to 40% and culminate in cirrhosis and end-stage liver disease. HCV can also cause hepatocellular carcinoma, generally on the background of cirrhosis with an incidence of 1% to 3% per year in this setting. After 2 decades of hard and prolonged treatments with interferon-based regimens that resulted in cure rates of less than 50%, successive generations of HCV specific direct-acting antivirals CYN-154806 were introduced that now result in remedy rates of 95% to 100% across all genotypes after only 8 to 12 weeks of nontoxic oral therapy. This unprecedented efficacy has led to speculation that HCV contamination might be eradicated even in the absence of a vaccine, but there are numerous impediments to global eradication including ascertainment of silent service Rabbit Polyclonal to OR providers, access to medication, and high drug cost. Nonetheless, we are in a new era of HCV control and optimism abounds. INTRODUCTION We have reached the point in the hepatitis C computer virus (HCV) epoch where greater than 95% of cases can be cured irrespective of the original mode of transmission, the viral genotype and, in most cases, the stage of hepatic fibrosis, including compensated cirrhosis. Recent therapeutic advances have been so remarkable that there is now rational speculation that HCV contamination might be globally eradicated, even in the absence of a vaccine. This manuscript will deal with the back-story of this journey that encompasses only 50 years since discovery of the Australia antigen, the first bona fide marker for any hepatitis computer virus. FROM HIPPOCRATES TO THE AUSTRALIA ANTIGEN Hippocrates is usually credited with the first description of jaundice (ikteros) accompanied by the symptoms that we now associate with viral hepatitis. This description in approximately 400 BCE has confirmed accurate, even though causation has had many iterations. Hippocrates attributed ikteros to an excess of one of the four humors, namely yellow bile. Although Hippocrates’ sense of humors may have been arcane, his observations, including hardening of the liver that he termed kirros, have withstood the test of time. Regrettably, there were no major improvements in understanding the causation of this form of jaundice over the next 2,000 years, but there were many observations of its occurrence and its epidemiology. No substantive insights into the etiology of hepatitis were advanced until the CYN-154806 late 1800s when an outbreak of hepatitis among shipyard workers in Bremen, Germany, was traced to the receipt of smallpox vaccine that had been CYN-154806 admixed with human serum (1), and then in the 1800s when several outbreaks of jaundice were linked to human plasmaCcontaminated vaccines for smallpox and serum-laced Salvarson (arsphenamine) for treating syphilis. Clearly, there appeared to be a transmissible, icterogenic agent residing in human plasma/serum. Notably, every war throughout the hundreds of years was marked by massive outbreaks of jaundice that we now know were predominantly cases of infectious hepatitis. CYN-154806 However, many cases were traced to the percutaneous inoculation of products contaminated with human blood, including 42,000 cases of icteric hepatitis and probably 5 occasions that number of anicteric hepatitis cases occurring in World War II that were traced to contaminated lots of yellow fever vaccine and later shown to be caused by hepatitis B computer virus (HBV) (2). Considerable studies by the army during and after World War II characterized two forms.